CVSA
Covista Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- B Mar 11 1 insider buy $897.3K at $100.94
- R Apr 9 Covista Inc. released an investor newsletter highlighting its strate…
- S Jun 10 to Jun 11 2 days of insider sells: $690.2K by 1 insider, avg $130.45
- S Jul 7 to Jul 13 3 days of insider sells: $2.1M by 3 insiders, avg $134.50
- S Aug 7 to Aug 11 2 days of insider sells: $1.4M by 3 insiders, avg $133.78
- A Sep 3 Truist Securities downgrades
- X Sep 30 Short interest jumps 31.2% to 2.54M
- S Oct 8 to Oct 9 2 days of insider sells: $1.1M by 1 insider, avg $130.59
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $897.3K at an average $100.94. 5 insiders sold $10.3M. Price is 30% above their cost.
- InstitutionsMIXED
Q2 2026: 23 added (0 new), 24 trimmed or exited.
- AnalystsBULLISH
8 of 10 rate it Buy or better. Every target is above the price.
- Short sellersBUILDING
Short interest +31.2% to 2.54M shares. 6.1 days to cover, ≈7.5% of shares.
- TrendUPTREND
3% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | $95.7M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | TRIM | $24.2M |
| Nuveen, LLC | ADD | $23.9M |
| GOLDMAN SACHS GROUP INC | TRIM | $20.3M |
| MACKENZIE FINANCIAL CORP | DOUBLED | $13.5M |
| WELLS FARGO & COMPANY/MN | ADD | $12.8M |
| Qube Research & Technologies Ltd | DOUBLED | $12.6M |
| UBS Group AG | TRIM | $8.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
10 analystsPrice is below the lowest target. Median implies +22%.Targets as of Oct 26, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 5, 2026 | BMO Capital MAINTAIN | Outperform |
| Sep 3, 2026 | Truist Securities DOWNGRADE | Hold |
| Jun 8, 2026 | Barrington Research MAINTAIN | Outperform |
| May 11, 2026 | Truist Securities MAINTAIN | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 15, 2026 | Hill Sara CHRO | TAX W/H | $168.2K |
| Oct 15, 2026 | CHIU EMILY C Director | AWARD | $33.0K |
| Oct 15, 2026 | Storms Leslie Director | AWARD | $33.0K |
| Oct 9, 2026 | Beard, Stephen W. Chairman & CEO | SELL | $610.3K |
| Oct 8, 2026 | Beard, Stephen W. Chairman & CEO | SELL | $474.4K |
| Aug 31, 2026 | MALAFRONTE MICHAEL W Director | GIFT | 2,500 sh |
| Aug 27, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | SELL | $247.2K |
| Aug 23, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | AWARD | $198.5K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 2026SecBot reports
14 filings · 2 bullish · 1 bearish · 11 neutral- NEUTRAL DEFA14AOct 14, 2026
Covista Inc. filed a DEFA14A proxy supplement clarifying that broker non-votes count only for…
Monitor the outcome of Proposal No. 4 (2026 Equity Incentive Plan) at the November 11 meeting — the clarification on broker non-votes may affect vote tally dynamics if retail turnout is low.
- NEUTRAL 144Oct 9, 2026
Director Stephen W. Beard filed a Form 144 notice of intent to sell 4,667 shares of Covista Inc…
The sale is pre-planned under a 10b5-1 plan adopted nearly 10 months ago, which significantly reduces the likelihood of material non-public information driving the trade. Monitor for any subsequent…
- NEUTRAL 144Oct 8, 2026
Director Stephen W. Beard filed a Form 144 notice of intent to sell 3,639 shares of Covista Inc…
This is a pre-planned 10b5-1 sale by a director, not a discretionary signal. The filing is routine and does not suggest any change in the insider's view of the company. Monitor for any acceleration…
- NEUTRAL DEFA14AOct 2, 2026
Covista Inc. filed a DEFA14A providing the notice of the 2026 Annual Meeting and proxy materials…
Monitor the annual meeting outcome for any significant vote against management proposals, particularly the say-on-pay and equity plan approval, which could signal shareholder discontent.
All CVSA filing & press-release reports (14)
- DEFA14A reportOct 14, 2026
- 144 reportOct 9, 2026
- 144 reportOct 8, 2026
- DEFA14A reportOct 2, 2026
- DEF 14A reportOct 2, 2026
- CLUSTER reportAug 13, 2026
- CLUSTER reportAug 11, 2026
- 8-K reportJul 28, 2026
- CLUSTER reportJul 15, 2026
- CLUSTER reportJul 15, 2026
- CLUSTER reportJul 9, 2026
- CLUSTER reportMay 8, 2026
- 8-K reportApr 9, 2026
- 8-K reportFeb 24, 2026